Trial Profile
Clinical Trials Insight: 700031899
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs AEG 33773 (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Aegera Therapeutics; Pharmascience
- 25 Mar 2008 New trial record.